NEW YORK (GenomeWeb News) — Former National Institutes of Health Director Elias Zerhouni has been named a US Science Envoy by State Department Secretary Hillary Clinton. Zerhouni is a senior fellow at the Bill & Melinda Gates Foundation’s Global Health Program and he is chief scientific adviser for the journal Science Translational Medicine.
The J. David Gladstone Institutes today announced that it has named Robert “Sandy” Williams as its new president, a post he will take over for Founding Director and President Robert Mahley.
Williams, who recently was senior vice chancellor for academic affairs at Duke University Medical Center, will step into the new position in March 2010.
Rosetta Genomics has appointed Kenneth Berlin as president and CEO. Berlin will also serve on the company’s board of directors. Since 2007 Berlin has been worldwide general manager at cellular and molecular cancer diagnostics company Veridex.
Nanoshpere said this week that Chief Technology Officer and VP of R&D William Cork has resigned from his positions to pursue other opportunities, and that his duties will be reassigned.
WaferGen Biosystems has appointed Christopher Sears to its scientific advisory board. Sears is CSO at Ambergen, and he has worked as an academic oncologist at Children’s Hospital Boston, The Broad Institute, Harvard Medical School, and Dana Farber Cancer Institute. Sears also has been a scientific adviser to Genzyme Genetics, Myriad Genetics, and Invitrogen.
William Brody has joined the board of directors at GenVault. Brody holds the Irwin Jacobs Presidential Chair at the Salk Institute and was formerly president of Johns Hopkins University. He also currently serves on national boards at IBM, Stanford University, and Novartis.
Neuroptix has named Werner Schaefer to its board of directors. Schaefer has held executive positions at Roche Diagnostics; was President and COO at Berhing Diagnostics; and director of area operations at Abbott GmbH Diagnostics.